{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T11:18:30Z","timestamp":1772623110323,"version":"3.50.1"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2023,7,4]],"date-time":"2023-07-04T00:00:00Z","timestamp":1688428800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,7,4]],"date-time":"2023-07-04T00:00:00Z","timestamp":1688428800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100014717","name":"National Outstanding Youth Science Fund Project of National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81725009"],"award-info":[{"award-number":["81725009"]}],"id":[{"id":"10.13039\/100014717","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Nucl Med Mol Imaging"],"published-print":{"date-parts":[[2023,10]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Purpose<\/jats:title>\n                <jats:p>PET\/MRI has become an important medical imaging approach in clinical practice. In this study, we retrospectively investigated the detectability of fluorine-18 (<jats:sup>18<\/jats:sup>F)-fluorodeoxyglucose positron emission tomography\/magnetic resonance imaging ([<jats:sup>18<\/jats:sup>F]FDG PET\/MRI) combined with chest computerized tomography (CT) for early cancer in a large cohort of asymptomatic subjects.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>This study included a total of 3020 asymptomatic subjects who underwent whole-body [<jats:sup>18<\/jats:sup>F]FDG PET\/MRI and chest HRCT examinations. All subjects received a 2\u20134-year follow-up for cancer development. Cancer detection rate, sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV) of the [<jats:sup>18<\/jats:sup>F]FDG PET\/MRI with or without chest HRCT were calculated and analyzed.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Sixty-one subjects were pathologically diagnosed with cancers, among which 59 were correctly detected by [<jats:sup>18<\/jats:sup>F]FDG PET\/MRI combined with chest HRCT. Of the 59 patients (32 with lung cancer, 9 with breast cancer, 6 with thyroid cancer, 5 with colon cancer, 3 with renal cancer, 1 with prostate cancer, 1 with gastric cancer, 1 with endometrial cancer, and 1 with lymphoma), 54 (91.5%) were at stage 0 or stage I (according to the 8th edition of the tumor-node-metastasis [TNM] staging system), 33 (55.9%) were detected by PET\/MRI alone (27 with non-lung cancers and 6 with lung cancer). Cancer detection rate, sensitivity, specificity, PPV, and NPV for PET\/MRI combined with chest CT were 2.0%, 96.7%, 99.6%, 83.1%, and 99.9%, respectively. For PET\/MRI alone, the metrics were 1.1%, 54.1%, 99.6%, 73.3%, and 99.1%, respectively, and for PET\/MRI in non-lung cancers, the metrics were 0.9%, 93.1%, 99.6%, 69.2%, and 99.9%, respectively.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>[<jats:sup>18<\/jats:sup>F]FDG PET\/MRI holds great promise for the early detection of non-lung cancers, while it seems insufficient for detecting early-stage lung cancers. Chest HRCT can be complementary to whole-body PET\/MRI for early cancer detection.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Trial registration<\/jats:title>\n                <jats:p>ChiCTR2200060041. Registered 16 May 2022. Public site: <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/www.chictr.org.cn\/index.html\">https:\/\/www.chictr.org.cn\/index.html<\/jats:ext-link><\/jats:p>\n              <\/jats:sec>","DOI":"10.1007\/s00259-023-06273-6","type":"journal-article","created":{"date-parts":[[2023,7,10]],"date-time":"2023-07-10T13:05:00Z","timestamp":1688994300000},"page":"3723-3734","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["[18F]FDG PET\/MRI combined with chest HRCT in early cancer detection: a retrospective study of 3020 asymptomatic subjects"],"prefix":"10.1007","volume":"50","author":[{"given":"Liling","family":"Peng","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi","family":"Liao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rui","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Han","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu","family":"Fu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Le","family":"Xue","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaohui","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mingxiang","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gang","family":"Feng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhaoting","family":"Meng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sisi","family":"Peng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xuexin","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gaojun","family":"Teng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xin","family":"Gao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4084-5150","authenticated-orcid":false,"given":"Hong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mei","family":"Tian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,7,4]]},"reference":[{"key":"6273_CR1","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/s13139-016-0393-1","volume":"50","author":"JH Jung","year":"2016","unstructured":"Jung JH, Choi Y, Im KC. PET\/MRI: technical challenges and recent advances. Nuclear Med Mol Imaging. 2016;50:3\u201312. https:\/\/doi.org\/10.1007\/s13139-016-0393-1.","journal-title":"Nuclear Med Mol Imaging."},{"key":"6273_CR2","doi-asserted-by":"publisher","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. 2021;71:209-49. https:\/\/doi.org\/10.3322\/caac.21660.","DOI":"10.3322\/caac.21660"},{"key":"6273_CR3","doi-asserted-by":"publisher","first-page":"e191460-e","DOI":"10.1001\/jamaoncol.2019.1460%J.JAMAOncology","volume":"5","author":"F Islami","year":"2019","unstructured":"Islami F, Miller KD, Siegel RL, Zheng Z, Zhao J, Han X, et al. National and state estimates of lost earnings from cancer deaths in the United States. JAMA Oncol. 2019;5:e191460-e. https:\/\/doi.org\/10.1001\/jamaoncol.2019.1460%J.JAMAOncology.","journal-title":"JAMA Oncol."},{"key":"6273_CR4","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1007\/s43657-021-00042-x","volume":"2","author":"X Zhang","year":"2022","unstructured":"Zhang X, Jiang H, Wu S, Wang J, Zhou R, He X, et al. Positron emission tomography molecular imaging for phenotyping and management of lymphoma. Phenomics. 2022;2:102\u201318. https:\/\/doi.org\/10.1007\/s43657-021-00042-x.","journal-title":"Phenomics."},{"key":"6273_CR5","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1053\/j.semnuclmed.2021.11.012","volume":"52","author":"R Seifert","year":"2022","unstructured":"Seifert R, Kersting D, Rischpler C, Opitz M, Kirchner J, Pabst KM, et al. Clinical use of PET\/MR in oncology: an update. Sem Nuclear Med. 2022;52:356\u201364. https:\/\/doi.org\/10.1053\/j.semnuclmed.2021.11.012.","journal-title":"Sem Nuclear Med."},{"key":"6273_CR6","doi-asserted-by":"publisher","first-page":"8714","DOI":"10.1007\/s00330-021-07956-0","volume":"31","author":"NM Bruckmann","year":"2021","unstructured":"Bruckmann NM, Kirchner J, Umutlu L, Fendler WP, Seifert R, Herrmann K, et al. Prospective comparison of the diagnostic accuracy of [18F]FDG PET\/MRI, MRI, CT, and bone scintigraphy for the detection of bone metastases in the initial staging of primary breast cancer patients. Eur Radiol. 2021;31:8714\u201324. https:\/\/doi.org\/10.1007\/s00330-021-07956-0.","journal-title":"Eur Radiol."},{"key":"6273_CR7","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1148\/radiol.2020192508","volume":"296","author":"AJ Theruvath","year":"2020","unstructured":"Theruvath AJ, Siedek F, Muehe AM, Garcia-Diaz J, Kirchner J, Martin O, et al. Therapy response assessment of pediatric tumors with whole-body diffusion-weighted MRI and FDG PET\/MRI. Radiol. 2020;296:143\u201351. https:\/\/doi.org\/10.1148\/radiol.2020192508.","journal-title":"Radiol."},{"key":"6273_CR8","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/s41824-021-00117-y","volume":"5","author":"AR Sharkey","year":"2021","unstructured":"Sharkey AR, Sah B-R, Withey SJ, Bhuva S, Neji R, Jeljeli S, et al. Initial experience in staging primary oesophageal\/gastro-oesophageal cancer with [18F]FDG PET\/MRI. Eur J Hybrid Imaging. 2021;5:23. https:\/\/doi.org\/10.1186\/s41824-021-00117-y.","journal-title":"Eur J Hybrid Imaging."},{"key":"6273_CR9","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1016\/S0895-4356(03)00166-5","volume":"56","author":"S Pita-Fern\u00e1ndez","year":"2003","unstructured":"Pita-Fern\u00e1ndez S, Montero-Martinez C, P\u00e9rtega-Diaz S, Verea-Hernando H. Relationship between delayed diagnosis and the degree of invasion and survival in lung cancer. J Clin Epidemiol. 2003;56:820\u20135. https:\/\/doi.org\/10.1016\/S0895-4356(03)00166-5.","journal-title":"J Clin Epidemiol."},{"key":"6273_CR10","doi-asserted-by":"publisher","unstructured":"Rivera-Franco MM, Leon-Rodriguez E. Delays in breast cancer detection and treatment in developing countries. 2018;12:1178223417752677. https:\/\/doi.org\/10.1177\/1178223417752677.","DOI":"10.1177\/1178223417752677"},{"key":"6273_CR11","doi-asserted-by":"publisher","first-page":"2338","DOI":"10.1007\/s00259-021-05234-1","volume":"48","author":"M Tian","year":"2021","unstructured":"Tian M, He X, Jin C, He X, Wu S, Zhou R, et al. Transpathology: molecular imaging-based pathology. Eur J Nuclear Med Mol Imaging. 2021;48:2338\u201350. https:\/\/doi.org\/10.1007\/s00259-021-05234-1.","journal-title":"Eur J Nuclear Med Mol Imaging."},{"key":"6273_CR12","doi-asserted-by":"publisher","unstructured":"Raad RA, Friedman KP, Heacock L, Ponzo F, Melsaether A, Chandarana H. Outcome of small lung nodules missed on hybrid PET\/MRI in patients with primary malignancy. 2016;43:504-11. https:\/\/doi.org\/10.1002\/jmri.25005.","DOI":"10.1002\/jmri.25005"},{"key":"6273_CR13","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.lungcan.2006.09.009","volume":"55","author":"J-Y Oh","year":"2007","unstructured":"Oh J-Y, Kwon S-Y, Yoon H-I, Lee SM, Yim J-J, Lee J-H, et al. Clinical significance of a solitary ground-glass opacity (GGO) lesion of the lung detected by chest CT. Lung Cancer (Amsterdam, Netherlands). 2007;55:67\u201373. https:\/\/doi.org\/10.1016\/j.lungcan.2006.09.009.","journal-title":"Lung Cancer (Amsterdam, Netherlands)."},{"key":"6273_CR14","doi-asserted-by":"publisher","unstructured":"Sch\u00e4fer JF, Gatidis S, Schmidt H, G\u00fcckel B, Bezrukov I, Pfannenberg CA, et al. Simultaneous whole-body PET\/MR imaging in comparison to PET\/CT in pediatric oncology: initial results. 2014;273:220-31. https:\/\/doi.org\/10.1148\/radiol.14131732.","DOI":"10.1148\/radiol.14131732"},{"key":"6273_CR15","doi-asserted-by":"publisher","unstructured":"Ohno Y, Koyama H, Yoshikawa T, Takenaka D, Seki S, Yui M, et al. Three-way comparison of whole-body MR, coregistered whole-body FDG PET\/MR, and integrated whole-body FDG PET\/CT imaging: TNM and stage assessment capability for non\u2013small cell lung cancer patients. 2015;275:849-61. https:\/\/doi.org\/10.1148\/radiol.14140936.","DOI":"10.1148\/radiol.14140936"},{"key":"6273_CR16","doi-asserted-by":"publisher","first-page":"93","DOI":"10.3322\/caac.21388","volume":"67","author":"MB Amin","year":"2017","unstructured":"Amin MB, Greene FL, Edge SB, Compton CC, Gershenwald JE, Brookland RK, et al. The Eighth Edition AJCC Cancer Staging Manual: continuing to build a bridge from a population-based to a more \u201cpersonalized\u201d approach to cancer staging. CA: a Cancer J Clin. 2017;67:93\u20139. https:\/\/doi.org\/10.3322\/caac.21388.","journal-title":"CA: a Cancer J Clin."},{"key":"6273_CR17","doi-asserted-by":"publisher","first-page":"1842","DOI":"10.1016\/j.ejca.2007.05.010","volume":"43","author":"S Kojima","year":"2007","unstructured":"Kojima S, Zhou B, Teramukai S, Hara A, Kosaka N, Matsuo Y, et al. Cancer screening of healthy volunteers using whole-body 18F-FDG-PET scans: The Nishidai clinic study. Europ J Cancer. 2007;43:1842\u20138. https:\/\/doi.org\/10.1016\/j.ejca.2007.05.010.","journal-title":"Europ J Cancer."},{"key":"6273_CR18","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1007\/s12149-012-0660-x","volume":"27","author":"R Minamimoto","year":"2013","unstructured":"Minamimoto R, Senda M, Jinnouchi S, Terauchi T, Yoshida T, Murano T, et al. The current status of an FDG-PET cancer screening program in Japan, based on a 4-year (2006\u20132009) nationwide survey. Annals Nuclear Med. 2013;27:46\u201357. https:\/\/doi.org\/10.1007\/s12149-012-0660-x.","journal-title":"Annals Nuclear Med."},{"key":"6273_CR19","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1007\/s12149-007-0061-8","volume":"21","author":"R Minamimoto","year":"2007","unstructured":"Minamimoto R, Senda M, Uno K, Jinnouchi S, Iinuma T, Ito K, et al. Performance profile of FDG-PET and PET\/CT for cancer screening on the basis of a Japanese Nationwide Survey. Annals Nuclear Med. 2007;21:481\u201398. https:\/\/doi.org\/10.1007\/s12149-007-0061-8.","journal-title":"Annals Nuclear Med."},{"issue":"66","key":"6273_CR20","doi-asserted-by":"publisher","first-page":"115","DOI":"10.3322\/caac.21338","volume":"2016","author":"W Chen","year":"2015","unstructured":"Chen W, Zheng R, Baade PD, Zhang S, Zeng H, Bray F, et al. Cancer Stat China. 2015;2016(66):115\u201332. https:\/\/doi.org\/10.3322\/caac.21338.","journal-title":"Cancer Stat China."},{"key":"6273_CR21","doi-asserted-by":"publisher","unstructured":"Liu Y. The place of FDG PET\/CT in renal cell carcinoma: value and limitations. 2016;6. https:\/\/doi.org\/10.3389\/fonc.2016.00201.","DOI":"10.3389\/fonc.2016.00201"},{"key":"6273_CR22","doi-asserted-by":"publisher","first-page":"1767","DOI":"10.1200\/jco.2008.18.2238","volume":"27","author":"S Nishizawa","year":"2009","unstructured":"Nishizawa S, Kojima S, Teramukai S, Inubushi M, Kodama H, Maeda Y, et al. Prospective evaluation of whole-body cancer screening with multiple modalities including [18F]fluorodeoxyglucose positron emission tomography in a healthy population: a preliminary report. J Clin Oncol Official J Am Soc Clin Oncol. 2009;27:1767\u201373. https:\/\/doi.org\/10.1200\/jco.2008.18.2238.","journal-title":"J Clin Oncol Official J Am Soc Clin Oncol."},{"key":"6273_CR23","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1007\/s00259-020-04955-z","volume":"48","author":"SE Dahlsgaard-Wallenius","year":"2021","unstructured":"Dahlsgaard-Wallenius SE, Hildebrandt MG, Johansen A, Vilstrup MH, Petersen H, Gerke O, et al. Hybrid PET\/MRI in non-small cell lung cancer (NSCLC) and lung nodules\u2014a literature review. Eur J Nuclear Med Mol Imaging. 2021;48:584\u201391. https:\/\/doi.org\/10.1007\/s00259-020-04955-z.","journal-title":"Eur J Nuclear Med Mol Imaging."},{"key":"6273_CR24","doi-asserted-by":"publisher","unstructured":"Mirshahvalad SA, Metser U, Basso Dias A, Ortega C, Yeung J, Veit-Haibach P. [18F]FDG PET\/MRI in detection of pulmonary malignancies: a systematic review and meta-analysis. Radiol. 2023:221598. https:\/\/doi.org\/10.1148\/radiol.221598.","DOI":"10.1148\/radiol.221598"},{"key":"6273_CR25","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1148\/radiol.211254","volume":"302","author":"Y Ohno","year":"2021","unstructured":"Ohno Y, Takenaka D, Yoshikawa T, Yui M, Koyama H, Yamamoto K, et al. Efficacy of ultrashort echo time pulmonary MRI for lung nodule detection and lung-RADS classification. Radiol. 2021;302:697\u2013706. https:\/\/doi.org\/10.1148\/radiol.211254.","journal-title":"Radiol."},{"key":"6273_CR26","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.1007\/s00259-015-3050-5","volume":"42","author":"B Schaarschmidt","year":"2015","unstructured":"Schaarschmidt B, Buchbender C, Gomez B, Rubbert C, Hild F, K\u00f6hler J, et al. Thoracic staging of non-small-cell lung cancer using integrated 18F-FDG PET\/MR imaging: diagnostic value of different MR sequences. Eur J Nuclear Med Mol Imaging. 2015;42:1257\u201367. https:\/\/doi.org\/10.1007\/s00259-015-3050-5.","journal-title":"Eur J Nuclear Med Mol Imaging."},{"key":"6273_CR27","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1148\/radiol.13130620","volume":"268","author":"H Chandarana","year":"2013","unstructured":"Chandarana H, Heacock L, Rakheja R, DeMello LR, Bonavita J, Block TK, et al. Pulmonary nodules in patients with primary malignancy: comparison of hybrid PET\/MR and PET\/CT imaging. Radiol. 2013;268:874\u201381. https:\/\/doi.org\/10.1148\/radiol.13130620.","journal-title":"Radiol."},{"key":"6273_CR28","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1016\/j.rcl.2018.01.005","volume":"56","author":"M Ciliberto","year":"2018","unstructured":"Ciliberto M, Kishida Y, Seki S, Yoshikawa T, Ohno Y. Update of MR imaging for evaluation of lung cancer. Radiol Clin North Am. 2018;56:437\u201369. https:\/\/doi.org\/10.1016\/j.rcl.2018.01.005.","journal-title":"Radiol Clin North Am."},{"key":"6273_CR29","doi-asserted-by":"publisher","unstructured":"Chandarana H, Heacock L, Rakheja R, DeMello LR, Bonavita J, Block TK, et al. Pulmonary nodules in patients with primary malignancy: comparison of Hybrid PET\/MR and PET\/CT imaging. 2013;268:874-81. https:\/\/doi.org\/10.1148\/radiol.13130620.","DOI":"10.1148\/radiol.13130620"},{"key":"6273_CR30","doi-asserted-by":"publisher","unstructured":"Ohno Y, Koyama H, Yoshikawa T, Seki S, Takenaka D, Yui M, et al. Pulmonary high-resolution ultrashort TE MR imaging: comparison with thin-section standard- and low-dose computed tomography for the assessment of pulmonary parenchyma diseases. 2016;43:512-32. https:\/\/doi.org\/10.1002\/jmri.25008.","DOI":"10.1002\/jmri.25008"},{"key":"6273_CR31","first-page":"181","volume":"22","author":"J Tong","year":"2016","unstructured":"Tong J, Zou Y, Jiang J, Shi W, Tao R, Ye J, et al. Cancer screening of asymptomatic individuals using 18F-FDG PET\/CT in China: a retrospective study. Discov Med. 2016;22:181\u20138.","journal-title":"Discov Med."},{"key":"6273_CR32","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1007\/BF03034001","volume":"21","author":"K Ono","year":"2007","unstructured":"Ono K, Ochiai R, Yoshida T, Kitagawa M, Omagari J, Kobayashi H, et al. The detection rates and tumor clinical\/pathological stages of whole-body FDG-PET cancer screening. Annals Nuclear Med. 2007;21:65\u201372. https:\/\/doi.org\/10.1007\/BF03034001.","journal-title":"Annals Nuclear Med."},{"key":"6273_CR33","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1097\/CM9.0000000000002108","volume":"135","author":"C Xia","year":"2022","unstructured":"Xia C, Dong X, Li H, Cao M, Sun D, He S, et al. Cancer statistics in China and United States, 2022: profiles, trends, and determinants. Chin Med J. 2022;135:584\u201390. https:\/\/doi.org\/10.1097\/CM9.0000000000002108.","journal-title":"Chin Med J."},{"key":"6273_CR34","doi-asserted-by":"publisher","first-page":"4437","DOI":"10.1007\/s00330-022-08584-y","volume":"32","author":"G Gheysens","year":"2022","unstructured":"Gheysens G, De Wever W, Cockmartin L, Bosmans H, Coudyzer W, De Vuysere S, et al. Detection of pulmonary nodules with scoutless fixed-dose ultra-low-dose CT: a prospective study. Eur Radiol. 2022;32:4437\u201345. https:\/\/doi.org\/10.1007\/s00330-022-08584-y.","journal-title":"Eur Radiol."},{"key":"6273_CR35","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1148\/radiol.210551","volume":"303","author":"B Jiang","year":"2022","unstructured":"Jiang B, Li N, Shi X, Zhang S, Li J, de Bock GH, et al. Deep learning reconstruction shows better lung nodule detection for ultra\u2013low-dose chest CT. Radiol. 2022;303:202\u201312. https:\/\/doi.org\/10.1148\/radiol.210551.","journal-title":"Radiol."},{"key":"6273_CR36","doi-asserted-by":"publisher","first-page":"1314","DOI":"10.1016\/j.surg.2015.03.017","volume":"158","author":"JH Yoon","year":"2015","unstructured":"Yoon JH, Cho A, Lee HS, Kim E-K, Moon HJ, Kwak JY. Thyroid incidentalomas detected on 18F-fluorodeoxyglucose-positron emission tomography\/computed tomography: Thyroid Imaging Reporting and Data System (TIRADS) in the diagnosis and management of patients. Surg. 2015;158:1314\u201322. https:\/\/doi.org\/10.1016\/j.surg.2015.03.017.","journal-title":"Surg."},{"key":"6273_CR37","doi-asserted-by":"publisher","first-page":"1290","DOI":"10.1097\/mnm.0000000000000592","volume":"37","author":"M Barrio","year":"2016","unstructured":"Barrio M, Czernin J, Yeh MW, Palma Diaz MF, Gupta P, Allen-Auerbach M, et al. The incidence of thyroid cancer in focal hypermetabolic thyroid lesions: an 18F-FDG PET\/CT study in more than 6000 patients. Nuclear Med Commun. 2016;37:1290\u20136. https:\/\/doi.org\/10.1097\/mnm.0000000000000592.","journal-title":"Nuclear Med Commun."},{"key":"6273_CR38","doi-asserted-by":"publisher","first-page":"342","DOI":"10.3348\/kjr.2018.19.2.342","volume":"19","author":"H Shi","year":"2018","unstructured":"Shi H, Yuan Z, Yuan Z, Yang C, Zhang J, Shou Y, et al. Diagnostic value of volume-based fluorine-18-fluorodeoxyglucose PET\/CT parameters for characterizing thyroid incidentaloma. kjr. 2018;19:342\u201351. https:\/\/doi.org\/10.3348\/kjr.2018.19.2.342.","journal-title":"kjr."},{"key":"6273_CR39","doi-asserted-by":"publisher","first-page":"1517","DOI":"10.1210\/jcem.87.4.8371%","volume":"87","author":"A Van den Bruel","year":"2002","unstructured":"Van den Bruel A, Maes A, De Potter T, Mortelmans L, Drijkoningen M, Van Damme B, et al. Clinical relevance of thyroid fluorodeoxyglucose-whole body positron emission tomography incidentaloma. The J Clin Endocrinol Metabol. 2002;87:1517\u201320. https:\/\/doi.org\/10.1210\/jcem.87.4.8371%.","journal-title":"The J Clin Endocrinol Metabol."},{"key":"6273_CR40","doi-asserted-by":"publisher","unstructured":"Chen W, Parsons M, Torigian DA, Zhuang H, Alavi A. Evaluation of thyroid FDG uptake incidentally identified on FDG-PET\/CT imaging. 2009;30:240-4. https:\/\/doi.org\/10.1097\/MNM.0b013e328324b431.","DOI":"10.1097\/MNM.0b013e328324b431"},{"key":"6273_CR41","doi-asserted-by":"publisher","first-page":"1607","DOI":"10.1054\/bjoc.2000.1496","volume":"83","author":"S Yasuda","year":"2000","unstructured":"Yasuda S, Ide M, Fujii H, Nakahara T, Mochizuki Y, Takahashi W, et al. Application of positron emission tomography imaging to cancer screening. British J Cancer. 2000;83:1607\u201311. https:\/\/doi.org\/10.1054\/bjoc.2000.1496.","journal-title":"British J Cancer."},{"key":"6273_CR42","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.2967\/jnumed.119.233940","volume":"61","author":"M Ole","year":"2020","unstructured":"Ole M, Benedikt MS, Julian K, Saravanabavaan S, Johannes G, Aydin D, et al. PET\/MRI versus PET\/CT for whole-body staging: results from a single-center observational study on 1,003 sequential examinations. J Nucl Med. 2020;61:1131. https:\/\/doi.org\/10.2967\/jnumed.119.233940.","journal-title":"J Nucl Med."},{"key":"6273_CR43","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1007\/s12149-021-01588-6","volume":"35","author":"I Alberts","year":"2021","unstructured":"Alberts I, Sachpekidis C, Prenosil G, Viscione M, Bohn KP, Mingels C, et al. Digital PET\/CT allows for shorter acquisition protocols or reduced radiopharmaceutical dose in [(18)F]-FDG PET\/CT. Annals Nuclear Med. 2021;35:485\u201392. https:\/\/doi.org\/10.1007\/s12149-021-01588-6.","journal-title":"Annals Nuclear Med."},{"key":"6273_CR44","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1186\/s12880-016-0143-y","volume":"16","author":"B Quinn","year":"2016","unstructured":"Quinn B, Dauer Z, Pandit-Taskar N, Schoder H, Dauer LT. Radiation dosimetry of 18F-FDG PET\/CT: incorporating exam-specific parameters in dose estimates. BMC Med Imaging. 2016;16:41. https:\/\/doi.org\/10.1186\/s12880-016-0143-y.","journal-title":"BMC Med Imaging."},{"key":"6273_CR45","doi-asserted-by":"publisher","first-page":"110646","DOI":"10.1016\/j.radphyschem.2022.110646","volume":"204","author":"S Almaasfeh","year":"2023","unstructured":"Almaasfeh S, Salahudeen A, Salih M, Abukonna A. Estimation of effective and organ dose from chest CT. Radiat Phys Chem. 2023;204:110646. https:\/\/doi.org\/10.1016\/j.radphyschem.2022.110646.","journal-title":"Radiat Phys Chem."},{"key":"6273_CR46","doi-asserted-by":"publisher","unstructured":"Wang C, Shi Z, Li Y, Xia X, Kuang X, Qian S, et al. Protocol for brain magnetic resonance imaging and extraction of imaging-derived phenotypes from the China Phenobank Project. Phenom. 2023. https:\/\/doi.org\/10.1007\/s43657-022-00083-w.","DOI":"10.1007\/s43657-022-00083-w"}],"updated-by":[{"DOI":"10.1007\/s00259-023-06370-6","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2023,8,23]],"date-time":"2023-08-23T00:00:00Z","timestamp":1692748800000}}],"container-title":["European Journal of Nuclear Medicine and Molecular Imaging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-023-06273-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00259-023-06273-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-023-06273-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,3]],"date-time":"2023-10-03T09:06:08Z","timestamp":1696323968000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00259-023-06273-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,4]]},"references-count":46,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2023,10]]}},"alternative-id":["6273"],"URL":"https:\/\/doi.org\/10.1007\/s00259-023-06273-6","relation":{"correction":[{"id-type":"doi","id":"10.1007\/s00259-023-06370-6","asserted-by":"object"}]},"ISSN":["1619-7070","1619-7089"],"issn-type":[{"value":"1619-7070","type":"print"},{"value":"1619-7089","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,7,4]]},"assertion":[{"value":"13 March 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 May 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 July 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 August 2023","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1007\/s00259-023-06370-6","URL":"https:\/\/doi.org\/10.1007\/s00259-023-06370-6","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was performed in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. The approval was granted by Shanghai Ethics Committee for Clinical Research (No. SECCR\/2021-125-01).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"For this type of study, formal consent is not required.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}